Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Stocks
Mankind Pharma Ltd.
Swot
Mankind Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats
Mankind Pharma Ltd. has 12 Strengths, 11 Weaknesses, 0 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential
Add SWOT widget to your site/app
Strengths
(12)
Weakness
(11)
Opportunity
(0)
Threats
(2)
Others
(2)
MACD Crossover Above Signal Line
Benjamin Graham Value Screen
Price crossing above SMA20 today, and greater than SMA5
Expensive Performers (DVM)
Relative Outperformance versus Industry over 1 Week
Growth in Net Profit with increasing Profit Margin (QoQ)
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
MACD crossed above signal line previous end of day
Volume Shockers
Promoter decreasing their shareholding
PE higher than Industry PE
PEG greater than Industry PEG
High PE (PE > 40)
Stocks with Expensive Valuations according to the Trendlyne Valuation Score
Declining Net Cash Flow : Companies not able to generate net cash
Increasing Trend in Non-Core Income
High volume, top losers
Top Losers
Declining profitability: Falling ROCE
Stocks Underperforming their Industry Price Change in the Quarter
Companies with high market cap, lower public shareholding
MFs decreased their shareholding last quarter
Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks
Average Bullish Trend - Stocks with Medium Trendlyne Momentum Score versus Benchmarks
